Lecanemab: Experimental drug is a ray of hope for Alzheimer’s disease

December 22, 2022

On Nov. 30, Eisai and Biogen announced the results of their latest phase 3 clinical trial in Alzheimer’s disease. The verdict: an 18-month treatment with lecanemab slows functional and cognitive loss by 27 percent in people with mild cognitive impairment or mild dementia due to Alzheimer’s disease. The study results were also published in the New England Journal of Medicine.

From aesthetics to precision: How clear aligners are transforming orthodontic care
Malocclusion affects nearly half of the global population, impacting oral function and aesthetics. Clear aligners have gained popularity due to their discreet appearance and ease of use, but their effectiveness varies depending on the type of tooth movement required.
USDA drops plan to limit salmonella in poultry products
The U.S. Department of Agriculture (USDA) has dropped plans to require poultry companies to limit salmonella bacteria in chicken and turkey products, ending a Biden administration effort to reduce foodborne illness.
Community resources help food-insecure kids make fewer ER visits
In a new clinical study published in JAMA Pediatrics, researchers at the University of Chicago Medicine found that a low-intensity program that "prescribes" community resources to every parent or other primary caregiver of a hospitalized child reduced the use of acute care for children of food-insecure families in the following year, saving potentially thousands of dollars in health care expenditures while demanding little more than minutes of staff time per family.
Landmark women's health study saved from funding cuts
In a sudden about-face, the U.S. Department of Health and Human Services (HHS) said it won't slash funding for the Women's Health Initiative, a major research project focused on preventing disease in older women.
Compact gene circuit uses microRNA to fine-tune therapy for rare diseases
Many diseases are caused by a missing or defective copy of a single gene. For decades, scientists have been working on gene therapy treatments that could cure such diseases by delivering a new copy of the missing genes to the affected cells.

Lecanemab: Experimental drug is a ray of hope for Alzheimer’s disease

Recent Posts

JUST IN